PRL also imparts a partial recovery of CPT1 enzyme activity in breast cancer cells in which AMPKα-1 is transiently knocked down, indicating that PRL-mediated AMPK activation contributes to the changes in CPT1 enzyme activity reported here. Here, PRL is linked to breast carcinoma.